Last reviewed · How we verify
Sufentanil 5 microgram/ml
Sufentanil 5 microgram/ml is a Opioid agonist Small molecule drug developed by Rigshospitalet, Denmark. It is currently FDA-approved for Acute pain management during and after surgery, Sedation in intensive care units, Perioperative analgesia. Also known as: Sufentanil.
Sufentanil is a potent synthetic opioid agonist that binds to mu (μ) opioid receptors in the central nervous system to produce analgesia and sedation.
Sufentanil is a potent synthetic opioid agonist that binds to mu (μ) opioid receptors in the central nervous system to produce analgesia and sedation. Used for Acute pain management during and after surgery, Sedation in intensive care units, Perioperative analgesia.
At a glance
| Generic name | Sufentanil 5 microgram/ml |
|---|---|
| Also known as | Sufentanil |
| Sponsor | Rigshospitalet, Denmark |
| Drug class | Opioid agonist |
| Target | Mu (μ) opioid receptor |
| Modality | Small molecule |
| Therapeutic area | Anesthesia and Pain Management |
| Phase | FDA-approved |
Mechanism of action
Sufentanil activates mu opioid receptors throughout the brain and spinal cord, inhibiting pain signal transmission and producing profound analgesia. It is approximately 5-10 times more potent than fentanyl and is used for acute pain management and sedation in clinical settings. The 5 microgram/ml formulation is typically administered intravenously or as an infusion for perioperative anesthesia and intensive care sedation.
Approved indications
- Acute pain management during and after surgery
- Sedation in intensive care units
- Perioperative analgesia
Common side effects
- Respiratory depression
- Hypotension
- Bradycardia
- Nausea and vomiting
- Chest wall rigidity
- Pruritus
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sufentanil 5 microgram/ml CI brief — competitive landscape report
- Sufentanil 5 microgram/ml updates RSS · CI watch RSS
- Rigshospitalet, Denmark portfolio CI
Frequently asked questions about Sufentanil 5 microgram/ml
What is Sufentanil 5 microgram/ml?
How does Sufentanil 5 microgram/ml work?
What is Sufentanil 5 microgram/ml used for?
Who makes Sufentanil 5 microgram/ml?
Is Sufentanil 5 microgram/ml also known as anything else?
What drug class is Sufentanil 5 microgram/ml in?
What development phase is Sufentanil 5 microgram/ml in?
What are the side effects of Sufentanil 5 microgram/ml?
What does Sufentanil 5 microgram/ml target?
Related
- Drug class: All Opioid agonist drugs
- Target: All drugs targeting Mu (μ) opioid receptor
- Manufacturer: Rigshospitalet, Denmark — full pipeline
- Therapeutic area: All drugs in Anesthesia and Pain Management
- Indication: Drugs for Acute pain management during and after surgery
- Indication: Drugs for Sedation in intensive care units
- Indication: Drugs for Perioperative analgesia
- Also known as: Sufentanil
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing